Filing Flows › GoodRx Holdings (GDRX) › Q2 2025
GoodRx Holdings (GDRX) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 6, 2025
GoodRx Holdings (GDRX) reported revenue of $203M for the second quarter 2025 (Q2 2025), +1% from a year earlier and 0% from the quarter before. Operating margin was 13.2%, net earnings $12.8M (6.3% of revenue).
GoodRx Holdings, Q2 2025: revenue $203M (+1% year over year), operating margin 13.2%, net earnings $12.8M, operating cash flow $49.6M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $203M | 0% | +1% |
| Operating profit | $26.8M | +15% | +35% |
| Net earnings | $12.8M | +16% | +92% |
| Operating cash flow | $49.6M | +427% | +411% |
| Free cash flow | $49.2M | +431% | +421% |
What changed
Revenue was $203.1M in Q2 2025, up 1% year over year and roughly flat from the previous quarter. Prescription transactions revenue was the largest line at 70% of revenue. Pharma manufacturer solutions revenue added $8.5M year over year (up 32%), 345% of the total change. Other revenue declined 16%.
Operating profit was $26.8M, a 13.2% margin (up 3.3 points year over year). Of the extra revenue versus a year earlier, 282% reached operating profit, above the 10% margin then. Total costs fell 2% while revenue rose 1%. The fastest-growing cost line was Other operating costs (+16%). Net earnings were $12.8M, up 92% year over year. The effective tax rate was 34.4%.
Operating cash flow was $49.6M (up 411% year over year), 386% of net earnings. Non-cash charges added back $19.7M of depreciation and amortization and $21.4M of share-based compensation. Working capital and other items used $4.4M. Capital expenditures of $390K left free cash flow of $49.2M.
Questions
What was GoodRx Holdings' revenue in the second quarter 2025?
GoodRx Holdings (GDRX) reported revenue of $203M for the second quarter 2025 (Q2 2025), +1% from a year earlier and 0% from the quarter before.
Was GoodRx Holdings profitable in the second quarter 2025?
Operating profit was $26.8M (13.2% of revenue) and net earnings $12.8M.
Source: GoodRx Holdings 10-Q on SEC EDGAR.